trimetazidine has been researched along with pyrroles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhonde, R; Govindasamy, V; Mamidi, MK; Pal, R; Zakaria, Z | 1 |
| Grabowski, T; Jaroszewski, JJ; Sasinowska-Motyl, M | 1 |
2 other study(ies) available for trimetazidine and pyrroles
| Article | Year |
|---|---|
Treat the graft to improve the regenerative ability of the host.
Topics: Atorvastatin; Cell Survival; Diazoxide; Heptanoic Acids; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Pyrroles; Regeneration; Regenerative Medicine; Transplants; Trimetazidine | 2011 |
Leave-one-out procedure in the validation of elimination rate constant analysis.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Antifungal Agents; Atorvastatin; Dosage Forms; Drug Design; Female; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Itraconazole; Male; Middle Aged; Perindopril; Pharmaceutical Preparations; Pharmacokinetics; Pyrroles; Reproducibility of Results; Therapeutic Equivalency; Trimetazidine; Vasodilator Agents; Young Adult | 2012 |